EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Cerebral Ischemia Protection After Aneurysmal Subarachnoid Hemorrhage: CSF Nimodipine Levels After Intravenous Versus Oral Nimodipine Administration

Miriam M Moser iD, Karl Rössler iD, Dorian Hirschmann, Leon Gramss, Ammar Tahir iD, Walter Plöchl iD, Johannes Herta iD, Andrea Reinprecht iD, Markus Zeitlinger iD, Arthur Hosmann iD

Clinical Pharmacology & Therapeutics · 2025

DOI: 10.1002/cpt.3499 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Clinical Pharmacology & Therapeutics, 2025. Verfasst von Miriam M Moser und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Nimodipine, Subarachnoid Hemorrhage, Brain Ischemia, Calcium Channel Blockers. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund FWF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is accumulating evidence that cerebrospinal fluid (CSF) concentrations of nimodipine correlate with long‐term outcome of patients after subarachnoidal hemorrhage (aSAH) by impeding cerebral ischemia. However, pharmacological data on simultaneous serum vs. CSF and intraparenchymal nimodipine values are rarely reported in larger patient groups. Nimodipine concentrations were determined in plasma, CSF, and cerebral interstitial fluid (ISF), at steady state after oral (6 × 60 mg/day) and intravenous (0.5, 1, 1.5 and 2 mg/h) administrations in 10 patients after aSAH. Area under the concentration time curve (AUC 0–24 ) for intravenous nimodipine was highest at an infusion rate of 2 mg/h in plasma (1335.87 ± 591.09 mg*h/L), followed by CSF (39.53 ± 23.07 mg*h/L), resulting in an overall CSF penetration ratio of 3.8% (±1.5) (AUC CSF /AUC plasma ). In contrast, nimodipine levels were significantly lower in both plasma (AUC 0–24 298.32 ± 206.52 mg*h/L) and CSF (AUC 0–24 34.8 ± 16.56 mg*h/L) after oral administration. In cerebral ISF, low amounts of nimodipine were detectable in only 4 patients at an infusion rate of 1.5 and 2 mg/h as well as following oral administration. We found significantly higher CSF nimodipine levels in patients during intravenous compared to oral administration. In contrast, only low amounts of nimodipine were detected in the ISF after both oral and intravenous administration. Our findings strongly suggest that the main clinical nimodipine effect of impeding life threatening cerebral ischemia is mediated through significant higher CSF levels after intravenous administration, more likely effective than oral administration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NimodipineSubarachnoid HemorrhageBrain IschemiaCalcium Channel BlockersHumansAdministration, OralMaleMiddle AgedFemaleAdministration, IntravenousAdultInfusions, IntravenousAgedArea Under Curve

Substanzen

NimodipineCalcium Channel Blockers

Autor:innen und Institutionen

  • Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.
  • Department of Pharmaceutical Sciences, University of Vienna, Vienna, Austria.
  • Department of Anaesthesia, Intensive Care Medicine and Pain Medicine, Division of General Anaesthesia and Intensive Care Medicine, Medical University of Vienna, Vienna, Austria.
  • Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

ORCID-Profile: Miriam M Moser, Karl Rössler, Ammar Tahir, Walter Plöchl, Johannes Herta, Andrea Reinprecht, Markus Zeitlinger, Arthur Hosmann

Förderung

  • Austrian Science Fund FWF

Zitieren

APA

Moser, M. M., Rössler, K., Hirschmann, D., Gramss, L., Tahir, A., Plöchl, W., Herta, J., Reinprecht, A., Zeitlinger, M., & Hosmann, A. (2025). Cerebral Ischemia Protection After Aneurysmal Subarachnoid Hemorrhage: CSF Nimodipine Levels After Intravenous Versus Oral Nimodipine Administration. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.3499

Vancouver

Moser MM, Rössler K, Hirschmann D, Gramss L, Tahir A, Plöchl W, et al. Cerebral Ischemia Protection After Aneurysmal Subarachnoid Hemorrhage: CSF Nimodipine Levels After Intravenous Versus Oral Nimodipine Administration. Clinical Pharmacology & Therapeutics. 2025. doi:10.1002/cpt.3499

BibTeX
@article{Moser2025,
  author = {Moser, Miriam M and Rössler, Karl and Hirschmann, Dorian and Gramss, Leon and Tahir, Ammar and Plöchl, Walter and Herta, Johannes and Reinprecht, Andrea and Zeitlinger, Markus and Hosmann, Arthur},
  title = {Cerebral Ischemia Protection After Aneurysmal Subarachnoid Hemorrhage: CSF Nimodipine Levels After Intravenous Versus Oral Nimodipine Administration},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2025},
  doi = {10.1002/cpt.3499}
}
Kostenlos starten →